Latest News and Press Releases

OTTAWA, March 06, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”) reported today its unaudited financial results for Q1 2019. For the three-month period ended...

OTTAWA, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”) is pleased to announce that its partner in the Philippines, UNAHCO, has purchased 2 metric tons of OxC-beta™...

OTTAWA, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”) is pleased to announce that it has signed a partnership with CSA Animal Nutrition providing for the sales and...

OTTAWA, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”) reported its audited financial results for the year ended October 31, 2018. Unless otherwise noted, all figures are in...

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. OTTAWA, Jan. 18, 2019 ...

OTTAWA, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”) is pleased to announce its 2019 letter to shareholders by Chairman and interim CEO Kym Anthony. To our shareholders: ...

OTTAWA, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”) announces the appointment of  UHY McGovern Hurley LLP as auditors. UHY McGovern Hurley LLP has been appointed to carry...

OTTAWA, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or “Corporation”), a world leader in natural alternatives to antibiotics with its OxC-beta™ technology, today announced...

OTTAWA, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”), announces a clarification to its press release issued Monday, November 19th at 6:30 A.M. EST.  The previous NR had...

OTTAWA, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”), is pleased to announce that its partner in the Philippines, UNAHCO, has purchased 2 metric tonnes of OxC-beta™...